Overview

Study of Bronchodilation Effects of Cetirizine

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
Primary Objective : To compare the acute bronchodilatory effects of cetirizine 10 mg tablet and nebulized levalbuterol using impulse oscillometry technique in asthmatic subjects aged 18 to 65 years old who have allergic rhinitis and show clinical evidence of bronchial hyper-reactivity. Secondary Objective: To assess the bronchodilatory effects of cetirizine 10 mg tablet versus placebo after two weeks of therapy using impulse oscillometry technique in subjects 18 to 65 years old who have allergic rhinitis and show clinical evidence of bronchial hyper-reactivity.
Phase:
Phase 4
Details
Lead Sponsor:
California Allergy and Asthma Medical Group, Inc.
Collaborator:
McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.
Treatments:
Cetirizine